The Data Conundrum: Navigating Healthcare Privacy Legislation in Canada

The Canadian healthcare and health tech sector is one of the fastest-growing in the world. Globally, health technology — particularly AI-driven tools — is evolving far more quickly than the privacy legislation designed to govern it. That gap creates a genuine conundrum for data-driven organizations working with some of the most sensitive information in existence: personal health information.

For companies operating in the Canadian healthcare space, the legislative landscape is anything but straightforward. Across 10 provinces, 3 territories, and a federal government, there exists a layered and sometimes inconsistent patchwork of privacy laws. Navigating practices such as de-identification, data minimization, and third-party data sharing requires a clear understanding of which laws apply, where they overlap, and where they fall short.

This article provides an authoritative breakdown of the key Canadian privacy frameworks that govern personal information (PI) and personal health information (PHI) — and what organizations need to know to remain compliant while continuing to innovate.

Why Is Canadian Healthcare Privacy Legislation So Complex?

The protection of personal information and personal health information is a priority at every level of government in Canada. However, the way that protection is structured and enforced differs significantly depending on geography and sector.

Some provinces have enacted health privacy legislation that has been deemed "substantially similar" to the federal baseline — the Personal Information Protection and Electronic Documents Act (PIPEDA). Ontario, Nova Scotia, New Brunswick, and Newfoundland and Labrador all fall into this category. Healthcare providers and organizations operating in these provinces are generally exempt from PIPEDA and must instead comply with their respective provincial healthcare privacy laws.

In the remaining provinces and territories, where health-specific legislation has not been declared substantially similar to PIPEDA, the federal law may still apply. This creates an uneven terrain: a health tech company operating nationally could find itself subject to multiple overlapping frameworks simultaneously.

The challenge is compounded by the age of PIPEDA itself. The law came into force in 2004, well before cloud computing, AI-assisted diagnostics, and large-scale health data platforms became industry norms. It has not been meaningfully amended to reflect these technological shifts, leaving significant interpretive gaps for organizations trying to do the right thing.

What Is Replacing PIPEDA? Understanding Bill C-27 and the CPPA

Recognizing the need for modernization, the federal government is planning to repeal PIPEDA and replace it with a new framework introduced under Bill C-27, the Digital Charter Implementation Act. Bill C-27 proposes three distinct pieces of legislation: the Consumer Privacy Protection Act (CPPA), the Personal Information and Data Protection Tribunal Act (PIDTA), and the Artificial Intelligence and Data Act (AIDA).

The CPPA represents a significant overhaul. Unlike PIPEDA, it introduces a direct definition of de-identification, explicit guidance on consent exceptions, and clearer requirements around the technical and administrative safeguards organizations must apply when handling personal data. For any organization working with sensitive health data or building AI systems trained on it, the CPPA signals a more demanding compliance environment ahead.

As of the time of writing, Bill C-27 is undergoing its second reading. Organizations would be well-advised to begin aligning their data practices with its requirements now rather than waiting for royal assent.

If your organization handles personal or personal health information and needs to get ahead of these requirements, speak with Limina's team about a compliant de-identification strategy.

How Is De-Identified Data Defined Under Canadian Privacy Law?

De-identification is the cornerstone practice for organizations that need to use or share health data without compromising individual privacy. But the definition of "de-identified data" is not uniform across Canadian legislation — and those differences matter.

PIPEDA and the Absence of an Explicit Definition

PIPEDA applies to the collection, use, and disclosure of all personal information by organizations subject to federal law. Notably, it does not expressly define de-identification. Instead, the concept is implied through references to "anonymizing" data, which has created ambiguity around whether express or implied consent is required to generate de-identified data from PI in the first place. That lack of clarity has been a persistent challenge for organizations operating under PIPEDA.

How the CPPA Defines De-Identification

The proposed CPPA addresses this gap directly. It defines de-identification as the modification of personal information "so that an individual cannot be directly identified from it, though a risk of the individual being identified remains." This distinction between de-identification and full anonymization is important: de-identified data, under the CPPA, still carries residual re-identification risk, and the law acknowledges this explicitly.

Importantly, the CPPA provides a consent exception for de-identification. Section 20 states that knowledge and consent are not required to de-identify personal information, removing one of the longstanding interpretive barriers that PIPEDA left unresolved. However, the CPPA also requires (under section 74) that any technical and administrative safeguards applied must be proportionate to the purpose of de-identification and the sensitivity of the information involved. Organizations cannot simply strip a few identifiers and consider the job done.

Ontario's PHIPA: A Health-Specific Standard

Ontario's Personal Health Information Protection Act (PHIPA) provides a more precise definition tailored to health data. Under PHIPA, to de-identify personal health information means to "remove any information that identifies the individual or for which it is reasonably foreseeable in the circumstances that it could be utilized, either alone or with other information, to identify the individual."

The "reasonably foreseeable" standard is a meaningful one. It pushes organizations beyond simple direct identifier removal and requires them to assess indirect risks, including combinations of data fields that might render an individual identifiable even without a name or address attached.

Under PIPEDA, the CPPA, and PHIPA, there is broad consensus on one point: if a dataset cannot reasonably be used to identify an individual, it is no longer considered personal information and falls outside the regulatory scope of these laws. Organizations that successfully de-identify data may use and disclose it without notice or consent, provided they also comply with prohibitions on re-identification.

Quebec's Bill 64: Raising the Bar on Anonymization

Quebec's privacy modernization law, commonly known as Bill 64 (An Act to modernize legislative provisions as regards the protection of personal information), adds another layer of nuance. It distinguishes between de-identification and full anonymization, and sets a higher bar for the latter.

Under Bill 64, personal information is considered de-identified if "it no longer allows the person concerned to be directly identified." Anonymization, by contrast, requires that the information be rendered unable to identify the person, directly or indirectly, in a way that is irreversible and consistent with generally accepted best practices. Organizations that anonymize data under Bill 64 must do so according to criteria and terms determined by regulation.

This distinction is operationally significant. Organizations working in Quebec who wish to use data without any ongoing privacy obligations must meet a much higher standard than simple de-identification. The regulatory criteria for achieving true anonymization are still developing, making it even more important to work with technically rigorous de-identification tools from the outset.

Limina's linguist-built data de-identification platform is designed to meet these standards across jurisdictions. Because the solution understands language context and entity relationships within documents, rather than relying on pattern matching alone, it can accurately detect and redact both direct and indirect identifiers at scale, across more than 52 languages and 50+ entity types.

What Is Data Minimization and Why Does It Matter Under Canadian Law?

Data minimization is the principle that organizations should collect only the personal information that is genuinely necessary to fulfill a specific, identified purpose. It is a foundational best practice in privacy engineering and a legal requirement under multiple Canadian frameworks.

PIPEDA addresses data minimization directly through its Fair Information Principles, two of which are especially relevant for healthcare and health tech organizations.

Principle 4, Limiting Collection, states that "the collection of personal information must be limited to that which is needed for the purposes identified by the organization. Information must be collected by fair and lawful means."

Principle 5, Limiting Use, Disclosure, and Retention, states that "unless the individual consents otherwise or it is required by law, personal information can only be used or disclosed for the purposes for which it was collected. Personal information must only be kept as long as required to serve those purposes."

Together, these principles establish a clear mandate: collect less, use it only as intended, and dispose of it when it is no longer needed. For organizations managing large volumes of PHI, this translates into a direct obligation to implement technical controls that enforce minimization at the point of collection and throughout the data lifecycle.

In practice, this means building de-identification and redaction into data workflows from the beginning, not as an afterthought. Organizations in healthcare, pharma and life sciences, financial services, insurance, and contact centers all face this challenge, particularly as AI and analytics use cases demand access to richer datasets.

How Does Canadian Law Handle Data Sharing with Third-Party Service Providers?

One of the more nuanced and underdeveloped areas of Canadian healthcare privacy law concerns the relationship between organizations and their third-party service providers. This is particularly relevant for health tech companies that rely on cloud infrastructure, analytics vendors, or AI providers to process PHI on their behalf.

Unlike the European Union's General Data Protection Regulation (GDPR), which provides specific and detailed requirements for the exchange of personal information between data controllers and data processors, the CPPA addresses this issue at a higher level of generality. As of the current draft, it remains unclear whether the CPPA grants third-party service providers the right to de-identify personal information on behalf of an originating organization, and whether that service provider could subsequently use de-identified data for their own purposes.

The existing landscape at the provincial and federal level largely leaves this question unanswered or touches on it only obliquely. In the absence of explicit legislative guidance, a practical approach for organizations is to rely on robust service contracts that clearly delineate the obligations of both parties. Those contracts should specify what personal information is being transferred, for what purpose, under what security requirements, and with what restrictions on secondary use or re-identification.

This is not simply a matter of legal risk management. It is also a question of trust. When patients share their health data with a provider, they do so with an expectation that it will not be passed downstream without appropriate protections in place. Organizations that take data sharing agreements seriously, and that work only with service providers capable of meeting rigorous de-identification standards, are better positioned to maintain that trust.

If your organization is evaluating how to structure compliant data-sharing arrangements, connect with Limina's team to understand how de-identification technology can reduce risk across your vendor relationships.

What Are the Practical Implications for Healthcare Organizations?

Across PIPEDA, the CPPA, PHIPA, and Bill 64, several common themes emerge that healthcare organizations and health tech companies should internalize.

First, the definition of de-identification is moving toward greater precision and greater demand. Vague anonymization practices are no longer sufficient. Laws like the CPPA and Bill 64 are explicit that technical and administrative measures must be proportionate and documented, and that the standard for anonymization is high.

Second, data minimization is a legal obligation, not a best practice aspiration. Organizations collecting PHI must build governance structures around limitation at the point of collection, restriction of use to declared purposes, and secure retention and disposal schedules.

Third, the third-party data-sharing question will continue to grow in importance as health data flows increasingly across organizational and national boundaries. The absence of detailed legislative guidance is not a license to proceed without caution; it is a signal to invest in strong contractual and technical protections now, before more prescriptive rules arrive.

Fourth, compliance cannot be achieved through manual review alone. The volume and variety of health data in circulation today, including unstructured text, clinical notes, call transcripts, and more, demands automated, context-aware de-identification solutions that can operate at speed and scale without sacrificing accuracy.

Conclusion: Navigating a Landscape in Transition

Canada's healthcare privacy legislation is not static. The proposed replacement of PIPEDA with the CPPA, the ongoing implementation of Quebec's Bill 64, and the evolution of provincial frameworks all signal that the compliance landscape will continue to shift. For organizations that handle PI and PHI, that means building not just for current requirements, but for the direction of travel.

De-identification, data minimization, and careful third-party data governance are not obstacles to innovation. They are the foundation on which responsible, sustainable health data use is built. Organizations that invest in rigorous, linguist-designed de-identification infrastructure today are the ones best positioned to unlock the value of health data tomorrow, without putting patients or their compliance standing at risk.

‍